Hallucinogenic mushroom misuse reported to Texas poison centers
Mathias B. Forrester
Journal of Addictive Diseases May 18, 2020 DOI: 10.1080/10550887.2020.1785817 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Observational study Peer reviewed |
|---|---|
| Sample size | 486 |
| Population | Individuals with hallucinogenic mushroom misuse exposures reported to Texas poison centers |
| Duration | 2000-2018 |
| Topics | Psilocybin |
| Keywords | Hallucinogen Poison control Euphoriant Mushroom poisoning Injury prevention Ingestion Environmental health |
| Citations | 6 |
| Key findings | Hallucinogenic mushroom misuse exposures reported to Texas poison centers predominantly involved young adult males, with ingestion at home being common, and most patients were managed at healthcare facilities, with neurological effects being the most frequent clinical outcome. |
Abstract
Background: Hallucinogenic mushrooms are fungi that contain the substance psilocybin. When ingested, psilocybin can induce hallucinations, euphoria, and alterations in the perception of space and time. Ingestion of hallucinogenic mushrooms may result in adverse effects.
Objective: The objective of this study was to describe hallucinogenic mushroom misuse reported to poison centers.
Methods: Cases were exposures to hallucinogenic mushrooms reported to Texas poison centers during 2000-2018 where the exposure reason was Intentional - Misuse or Intentional - Abuse (combined into the term "misuse" in the study). The distribution of the cases was determined for various factors related to patient demographics, exposure circumstances, management, and outcome.
Results: Texas poison centers managed 486 hallucinogenic mushroom misuse exposures. Eighty-five percent of the patients were male; the mean age was 20.9 years (range 12-57 years). The exposure route was ingestion alone in 91% of the cases. Seventy-two percent of the exposures occurred at the patient's own residence. Seventy-one percent of the patients were already at or en route to a healthcare facility when the poison center was contacted, 22% were referred to a healthcare facility by the poison center, and 7% of the patients were managed on-site. The most frequent clinical effects were neurological (72%), cardiovascular (25%), and gastrointestinal (23%).
Conclusions: The majority of hallucinogenic mushroom misuse exposures involved adolescents or young adults and were male. Most of the exposures tended to be managed at a healthcare facility. The most common clinical effects tended to be neurological, cardiovascular, and gastrointestinal in nature.
Comparable studies
Other observational and cohort studies on psilocybin, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms. Patients with treatment-resistant depression | 2017 | Observational cohort | n = 19 |
| Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels Healthy volunteers | 2019 | Observational cohort | n = 8 |
| Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin Humans | 2017 | Observational study | |
| Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population. USA adult respondents from the National Survey on Drug Use and Health (2008-2012) | 2015 | Observational cohort | n = 190,000 |
| Prediction of Psilocybin Response in Healthy Volunteers Healthy volunteers | 2012 | Observational cohort | n = 409 |
Citations in the library
Cited by 2
Cites 6
- The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act Neuropharmacology June 5, 2018
- Effects of psilocybin on time perception and temporal control of behaviour in humans Journal of Psychopharmacology May 20, 2006
- Harm potential of magic mushroom use: a review. Regulatory toxicology and pharmacology : RTP April 1, 2011
- Does getting high hurt? Characterization of cases of LSD and psilocybin-containing mushroom exposures to national poison centers between 2000 and 2016 Journal of Psychopharmacology September 5, 2018
- Clinical toxicology of ‘magic mushroom’ ingestion Postgraduate Medical Journal September 1, 1981
and 1 more in the library